Community/Retail

Sixteen United States Senators and 30 members of the House of Representatives recently wrote to the Centers for Medicare & Medicaid Services urging the agency to finalize its proposed guidance on how Medicare prescription drug plan sponsors report pharmacy price concessions, often referred to as direct and indirect remuneration fees, to provide more accurate information to beneficiaries, pharmacies and the federal government.

America's Health Insurance Plans President and CEO Marilyn Tavenner and Generic Pharmaceutical Association President and CEO Chip Davis released a joint statement praising today's decision by the Supreme Court in Cuozzo v. Lee. AHIP and GPhA's filed a joint amicus brief in the case recognizing the inter partes review as a critical consumer protection against abusive patent activity in the prescription drug market.